180 related articles for article (PubMed ID: 24996227)
1. Quality of life in purely ocular myasthenia in Japan.
Suzuki S; Murai H; Imai T; Nagane Y; Masuda M; Tsuda E; Konno S; Oji S; Nakane S; Motomura M; Suzuki N; Utsugisawa K
BMC Neurol; 2014 Jul; 14():142. PubMed ID: 24996227
[TBL] [Abstract][Full Text] [Related]
2. [Treatment of pure ocular myasthenia: a proposal from Japan MG registry 2012].
Suzuki S
Rinsho Shinkeigaku; 2013; 53(11):1303-5. PubMed ID: 24291968
[TBL] [Abstract][Full Text] [Related]
3. Treatment of ocular symptoms in myasthenia gravis.
Bhanushali MJ; Wuu J; Benatar M
Neurology; 2008 Oct; 71(17):1335-41. PubMed ID: 18936425
[TBL] [Abstract][Full Text] [Related]
4. Development of generalized disease at 2 years in patients with ocular myasthenia gravis.
Kupersmith MJ; Latkany R; Homel P
Arch Neurol; 2003 Feb; 60(2):243-8. PubMed ID: 12580710
[TBL] [Abstract][Full Text] [Related]
5. [Ocular myasthenia: clinical course and strategies for treatment].
Marzo ME; Pérez López-Fraile I; Capablo JL; Ara JR; Usón M
Rev Neurol; 1998 Mar; 26(151):398-400. PubMed ID: 9585951
[TBL] [Abstract][Full Text] [Related]
6. [Correlation between oral corticosteroid therapy and present disease status in myasthenia gravis].
Imai T
Rinsho Shinkeigaku; 2013; 53(11):1306-8. PubMed ID: 24291969
[TBL] [Abstract][Full Text] [Related]
7. Medical and surgical treatment for ocular myasthenia.
Benatar M; Kaminski H
Cochrane Database Syst Rev; 2006 Apr; (2):CD005081. PubMed ID: 16625623
[TBL] [Abstract][Full Text] [Related]
8. Medical and surgical treatment for ocular myasthenia.
Benatar M; Kaminski H
Cochrane Database Syst Rev; 2012 Dec; 12(12):CD005081. PubMed ID: 23235620
[TBL] [Abstract][Full Text] [Related]
9. Decompensating esophoria as the presenting feature of myasthenia gravis.
Arblaster GE; Shipman TL; Pepper IM
J AAPOS; 2009 Jun; 13(3):310-1. PubMed ID: 19395293
[TBL] [Abstract][Full Text] [Related]
10. An atypical course of myasthenia gravis.
Labana SS; Qureshi S; Nandakumar T; Cervellione KL; Venkatraman GK; Thakore H; Gintautas J
Proc West Pharmacol Soc; 2007; 50():140-2. PubMed ID: 18605252
[TBL] [Abstract][Full Text] [Related]
11. An unusual presentation of myasthenia gravis.
Chijoke A; Ogunmodele JA
West Afr J Med; 2009; 28(6):391-3. PubMed ID: 20486100
[TBL] [Abstract][Full Text] [Related]
12. Ocular motor dysfunction and ptosis in ocular myasthenia gravis: effects of treatment.
Kupersmith MJ; Ying G
Br J Ophthalmol; 2005 Oct; 89(10):1330-4. PubMed ID: 16170126
[TBL] [Abstract][Full Text] [Related]
13. EFNS/ENS Guidelines for the treatment of ocular myasthenia.
Kerty E; Elsais A; Argov Z; Evoli A; Gilhus NE
Eur J Neurol; 2014 May; 21(5):687-93. PubMed ID: 24471489
[TBL] [Abstract][Full Text] [Related]
14. Cigarette Smoking and Activities of Daily Living in Ocular Myasthenia Gravis.
Gratton SM; Herro AM; Feuer WJ; Lam BL
J Neuroophthalmol; 2016 Mar; 36(1):37-40. PubMed ID: 26457691
[TBL] [Abstract][Full Text] [Related]
15. The effect of early prednisolone treatment on the generalization rate in ocular myasthenia gravis.
Zach H; Cetin H; Hilger E; Paul A; Wuschitz B; Jung R; Auff E; Zimprich F
Eur J Neurol; 2013 Apr; 20(4):708-13. PubMed ID: 23279780
[TBL] [Abstract][Full Text] [Related]
16. [Demographic and clinical characteristics of patients with myasthenia gravis].
Rastenyte D; Vaitkus A; Neverauskas R; Pauza V
Medicina (Kaunas); 2002; 38(6):611-6. PubMed ID: 12474667
[TBL] [Abstract][Full Text] [Related]
17. Rationale for the clinical guidelines for myasthenia gravis in Japan.
Murai H; Utsugisawa K; Nagane Y; Suzuki S; Imai T; Motomura M
Ann N Y Acad Sci; 2018 Feb; 1413(1):35-40. PubMed ID: 29377151
[TBL] [Abstract][Full Text] [Related]
18. Pseudo-internuclear ophthalmoplegia as a sign of overlapping myasthenia gravis in a patient with 'intractable' hypothyroidism.
Yamazaki Y; Sugiura T; Kurokawa K
Intern Med; 2010; 49(1):69-72. PubMed ID: 20046005
[TBL] [Abstract][Full Text] [Related]
19. Myasthenia gravis associated with novel coronavirus 2019 infection: A report of three cases.
Karimi N; Okhovat AA; Ziaadini B; Haghi Ashtiani B; Nafissi S; Fatehi F
Clin Neurol Neurosurg; 2021 Sep; 208():106834. PubMed ID: 34329810
[TBL] [Abstract][Full Text] [Related]
20. Eculizumab improves fatigue in refractory generalized myasthenia gravis.
Andersen H; Mantegazza R; Wang JJ; O'Brien F; Patra K; Howard JF;
Qual Life Res; 2019 Aug; 28(8):2247-2254. PubMed ID: 30905021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
